Bibliographic Info
GuidelineConsolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Year of Publication2014
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
High
Where serodiscordant couples can be identified and where additional HIV prevention choices for them are needed, daily oral PrEP (specifically tenofovir or the combination of tenofovir and emtricitabine) may be considered as a possible additional intervention for the uninfected partner
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects, July 2012
Year2012
InstitutionWorld Health Organization
Guideline
Consolidated guideline on sexual and reproductive health and rights of women living with HIV
Year2017
InstitutionWHO